908
Views
39
CrossRef citations to date
0
Altmetric
Original Research

Overcoming medication stigma in peer recovery: A new paradigm

, BA, , MHS, , MHS, , JD & , MD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Michael J. Broman, Emily Pasman, Suzanne Brown, Jamey J. Lister, Elizabeth Agius & Stella M. Resko. (2023) Social support is associated with reduced stigma and shame in a sample of rural and small urban adults in methadone treatment. Addiction Research & Theory 31:1, pages 37-44.
Read now
Wayne Kepner, Meredith C. Meacham & Alicia L. Nobles. (2022) Types and Sources of Stigma on Opioid Use Treatment and Recovery Communities on Reddit. Substance Use & Misuse 57:10, pages 1511-1522.
Read now
Emily Pasman. (2022) Reducing stigma toward medication for opioid use disorder through social work education, research, and practice. Journal of Social Work Practice in the Addictions 22:1, pages 86-92.
Read now
Erin Fanning Madden, Suzanne Prevedel, Timothy Light & Sandra H. Sulzer. (2021) Intervention Stigma toward Medications for Opioid Use Disorder: A Systematic Review. Substance Use & Misuse 56:14, pages 2181-2201.
Read now
Emily Pasman. (2021) Reducing stigma toward medication for opioid use disorder through social work education, research, and practice. Journal of Social Work Practice in the Addictions 0:0, pages 1-8.
Read now

Articles from other publishers (34)

Emily Pasman, Sydney O'Shay, Suzanne Brown, Erin Fanning Madden, Elizabeth Agius & Stella M. Resko. (2023) Ambivalence and contingencies: A qualitative examination of peer recovery coaches' attitudes toward medications for opioid use disorder. Journal of Substance Use and Addiction Treatment 155, pages 209121.
Crossref
Omeid Heidari, Abigail Winiker, Derek T. DangerfieldIIII, Jennifer Wenzel, Tamar Rodney, Shruti Mehta & Becky Genberg. (2023) Understanding healthcare engagement for people who inject drugs. Research in Nursing & Health.
Crossref
Jarratt D. Pytell, Anthony T. Fojo, Jeanne C. Keruly, LaQuita N. Snow, Oluwaseun Falade-Nwulia, Richard D. Moore, Geetanjali Chander & Catherine R. Lesko. (2023) Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use. Addiction Science & Clinical Practice 18:1.
Crossref
Antje M. Barreveld, Andrew Mendelson, Brittany Deiling, Catharina A. Armstrong, Eugene R. ViscusiLynn R. Kohan. (2023) Caring for Our Patients With Opioid Use Disorder in the Perioperative Period: A Guide for the Anesthesiologist. Anesthesia & Analgesia 137:3, pages 488-507.
Crossref
Sathya Dev Unudurthi, Kathy D. Wright, Jill M. Klimpel, Abhimanyu Sud, Alai Tan & Barbara J. Warren. (2023) Sudarshan Kriya Meditation Reduces Substance Abuse Cravings and Improves Physical and Emotional Well-Being of Individuals With Opioid Use Disorder: A Pilot Study. Journal of Psychosocial Nursing and Mental Health Services 61:8, pages 51-59.
Crossref
Ashley R. Houston, Dani Snyder-Young, Meghann Perry, Maren Flessen & Alisa K. Lincoln. (2023) ‘Let Others Love You Back to Health’: The Role of Performance-based Support Groups for People in Recovery. Community Mental Health Journal 59:6, pages 1097-1108.
Crossref
MAGDALENA CERDÁ, NOA KRAWCZYK & KATHERINE KEYES. (2023) The Future of the United States Overdose Crisis: Challenges and Opportunities. The Milbank Quarterly 101:S1, pages 478-506.
Crossref
Alexis Carl, Emily Pasman, Michael J. Broman, Jamey J. Lister, Elizabeth Agius & Stella M. Resko. (2023) Experiences of healthcare and substance use treatment provider-based stigma among patients receiving methadone. Drug and Alcohol Dependence Reports 6, pages 100138.
Crossref
Pia M. Mauro, Navdep Kaur, Melanie S. Askari & Katherine M. Keyes. (2023) Alcohol or Drug Self-Help Use Among Adults in the United States: Age, Period, and Cohort Effects Between 2002 and 2018. International Journal of Mental Health and Addiction.
Crossref
Kim Gannon & Emily Pasman. (2023) “Knowing or not knowing”: Living as harm reductionists in Twelve Step recovery. Journal of Substance Use and Addiction Treatment 145, pages 208954.
Crossref
Honora Englander, Jessica Gregg & Ximena A. Levander. (2022) Envisioning Minimally Disruptive Opioid Use Disorder Care. Journal of General Internal Medicine 38:3, pages 799-803.
Crossref
Thomas J. Stopka, Rebecca E. Rottapel, Warren J. Ferguson, Ekaterina Pivovarova, Lizbeth Del Toro-Mejias, Peter D. Friedmann & Elizabeth A. Evans. (2022) Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers. International Journal of Drug Policy 110, pages 103803.
Crossref
Michael R. Frone, L. Casey Chosewood, Jamie C. Osborne & John J. Howard. (2022) Workplace Supported Recovery from Substance Use Disorders: Defining the Construct, Developing a Model, and Proposing an Agenda for Future Research. Occupational Health Science 6:4, pages 475-511.
Crossref
Jason B. Gibbons, Jeffrey S. McCullough, Kara Zivin, Zach Y. Brown & Edward C. Norton. (2022) Association Between Buprenorphine Treatment Gaps, Opioid Overdose, and Health Care Spending in US Medicare Beneficiaries With Opioid Use Disorder. JAMA Psychiatry 79:12, pages 1173.
Crossref
Douglas B. Marlowe, David S. Theiss, Erika M. Ostlie & John Carnevale. (2022) Drug court utilization of medications for opioid use disorder in high opioid mortality communities. Journal of Substance Abuse Treatment 141, pages 108850.
Crossref
Ross J. Knaub, Julie Evans, Cui Yang, Raúl Roura, Tanner McGinn, Benjamin Verschoore, Erin P. Ricketts, Richard E. Rothman, Carl A. Latkin & Yu-Hsiang Hsieh. (2022) A pilot study of a mixed-method approach to design an ED-based peer mHealth referral tool for HIV/HCV and opioid overdose prevention services. Drug and Alcohol Dependence 238, pages 109585.
Crossref
Madeline R. Stenersen, Kathryn Thomas, Cara Struble, Kelly E. Moore, Catherine Burke & Sherry McKee. (2022) The impact of self-help groups on successful substance use treatment completion for opioid use: An intersectional analysis of race/ethnicity and sex. Journal of Substance Abuse Treatment 136, pages 108662.
Crossref
Suzanne Lane, Angela Moreland, Sazid Khan, Karen Hartwell, Louise Haynes & Kathleen Brady. (2022) Disparities in years of potential life lost to Drug-involved overdose deaths in South Carolina. Addictive Behaviors 126, pages 107181.
Crossref
Meredith C. Meacham, Alicia L. Nobles, D. Andrew Tompkins & Johannes Thrul. (2022) “I got a bunch of weed to help me through the withdrawals”: Naturalistic cannabis use reported in online opioid and opioid recovery community discussion forums. PLOS ONE 17:2, pages e0263583.
Crossref
Martha Tillson, Amanda Fallin-Bennett & Michele Staton. (2022) Providing peer navigation services to women with a history of opioid misuse pre- and post-release from jail: A program description. Journal of Clinical and Translational Science 6:1.
Crossref
Alex R. Dopp, Jennifer K. Manuel, Joshua Breslau, Barbara Lodge, Brian Hurley, Courtney Kase & Karen Chan Osilla. (2022) Value of family involvement in substance use disorder treatment: Aligning clinical and financing priorities. Journal of Substance Abuse Treatment 132, pages 108652.
Crossref
Erica Morse, Ingrid A. Binswanger, Emmeline Taylor, Caroline Gray, Matthew Stimmel, Christine Timko, Alex H.S. Harris, David Smelson & Andrea K. Finlay. (2021) Strategies to improve implementation of medications for opioid use disorder reported by veterans involved in the legal system: A qualitative study. Journal of Substance Abuse Treatment 129, pages 108353.
Crossref
Noa Krawczyk, Arthur Robin Williams, Brendan Saloner & Magdalena Cerdá. (2021) Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings. Journal of Substance Abuse Treatment 126, pages 108329.
Crossref
Bruce Wallace, Karen MacKinnon, Heather Strosher, Celeste Macevicius, Carol Gordon, Rebecca Raworth, Lacey Mesley, Sana Shahram, Lenora Marcellus, Karen Urbanoski & Bernadette Pauly. (2021) Equity-oriented frameworks to inform responses to opioid overdoses: a scoping review. JBI Evidence Synthesis 19:8, pages 1760-1843.
Crossref
Martha T. Kane & Windia Rodriguez. 2021. Treating Opioid Use Disorder in General Medical Settings. Treating Opioid Use Disorder in General Medical Settings 119 141 .
R. Craig Lefebvre, Redonna K. Chandler, Donald W. Helme, Robin Kerner, Sarah Mann, Michael D. Stein, Jennifer Reynolds, Michael D. Slater, Amarachi R. Anakaraonye, Dacia Beard, Olivia Burrus, Jenna Frkovich, Haley Hedrick, Nicky Lewis & Emma Rodgers. (2020) Health communication campaigns to drive demand for evidence-based practices and reduce stigma in the HEALing communities study. Drug and Alcohol Dependence 217, pages 108338.
Crossref
Noa Krawczyk, Ramin Mojtabai, Elizabeth A. Stuart, Michael Fingerhood, Deborah Agus, B. Casey Lyons, Jonathan P. Weiner & Brendan Saloner. (2020) Opioid agonist treatment and fatal overdose risk in a state‐wide US population receiving opioid use disorder services. Addiction 115:9, pages 1683-1694.
Crossref
Hefei WenBenjamin G. DrussBrendan Saloner. (2020) Self-Help Groups And Medication Use In Opioid Addiction Treatment: A National Analysis. Health Affairs 39:5, pages 740-746.
Crossref
Andrea Jakubowski & Aaron Fox. (2020) Defining Low-threshold Buprenorphine Treatment. Journal of Addiction Medicine 14:2, pages 95-98.
Crossref
Barbara Andraka-Christou, Thuy Nguyen, David W. Bradford & Kosali Simon. (2020) Assessing the impact of drug courts on provider-directed marketing efforts by manufactures of medications for the treatment of opioid use disorder. Journal of Substance Abuse Treatment 110, pages 49-58.
Crossref
Laura Palombi, Amanda N. Hawthorne, Andrew Irish, Emily Becher & Elizabeth Bowen. (2019) “One Out of Ten Ain’t Going to Make It”: An Analysis of Recovery Capital in the Rural Upper Midwest. Journal of Drug Issues 49:4, pages 680-702.
Crossref
C. Truong, N. Krawczyk, M. Dejman, S. Marshall-Shah, K. Tormohlen, D. Agus & J. Bass. (2019) Challenges on the road to recovery: Exploring attitudes and experiences of clients in a community-based buprenorphine program in Baltimore City. Addictive Behaviors 93, pages 14-19.
Crossref
Kenneth A. Feder, Noa Krawczyk, Ramin Mojtabai, Rosa M. Crum, Gregory Kirk & Shruti H. Mehta. (2019) Health insurance coverage is associated with access to substance use treatment among individuals with injection drug use: Evidence from a 12-year prospective study. Journal of Substance Abuse Treatment 96, pages 75-81.
Crossref
Brittany D'Ambrosio, Peter J. Davidson, Jen Bowles, Maria Luisa Mittal, Sarah E. Clingan, Tommi L. Gaines & Laramie R. Smith. (2022) Attitudes Towards Medication for Opioid Use Disorders in Southern California: A Qualitative Study. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.